U.S. Consumer Services Stock News

In December 2025, Vestis Corporation reported fourth-quarter sales of US$712.01 million and a quarterly net loss of US$12.55 million, alongside a full-year net loss of US$40.22 million on sales of US$2,734.84 million, reversing the prior year’s profitability. Alongside these widened losses, Vestis guided for fiscal 2026 revenue to be flat to down 2% versus normalized 2025 levels, underscoring management’s cautious outlook on demand and execution. We’ll now examine how Vestis’s wider losses...

Wondering if Kroger at around $63 a share is still a smart buy or if the easy money has already been made? This breakdown is designed to give you a clear, valuation first answer. The stock is up 0.8% over the last week and 2.0% year to date, but that sits against a modest 3.9% gain over 1 year and much stronger returns of 52.4% over 3 years and 127.7% over 5 years, hinting at a long term uptrend that has cooled recently. Recent headlines have centered on Kroger's ongoing antitrust scrutiny...

RPC (RES) has been grinding through a mixed performance lately, with shares slipping over the past week but climbing about 27% in the past 3 months. This has left investors weighing value against cyclical risk. See our latest analysis for RPC. At around $5.68, RPC’s recent 90 day share price return of 27.07% contrasts with a weaker year to date performance. This suggests short term momentum is rebuilding even as longer term total shareholder returns remain uneven. If RPC’s rebound has you...

Wondering if JinkoSolar Holding at around $25.64 is a bargain or a value trap? You are not alone. This stock often flies under the radar despite big swings in sentiment. Over the last week the share price is up 5.9%, but that bounce comes after a choppy stretch, with the stock down 6.1% over 30 days and still negative over 1 year and even more over 3 and 5 years. Recently, JinkoSolar has stayed in the spotlight with ongoing headlines about global clean energy policy shifts and intensifying...

The US Supreme Court’s earlier decision to review the government’s use of the International Economic Emergency Powers Act (IEEPA) for tariffs has introduced the risk that multiple 2025 bilateral tariff arrangements could be revisited, raising the prospect of renewed trade friction and supply chain disruption into 2026 for corporate clients worldwide. For Marsh & McLennan, a leading global risk and insurance adviser, this heightened policy and trade uncertainty sharpens the relevance of its...

If you are wondering whether Monolithic Power Systems is still worth buying after its massive run, or if the best days are already priced in, you are not alone. The stock is trading around $946.51, down a modest 1.7% over the last week and 1.2% over the last month, but still up an impressive 59.3% year to date and 56.9% over the past year, with multi year gains above 160%. Recent enthusiasm has been driven by Monolithic Power Systems' expanding role in power management solutions for data...

Q3 2025 Snapshot and Recent Trends Evommune (EVMN) just posted Q3 2025 results with revenue of about $10 million and a basic EPS loss of roughly $8.07, while trailing twelve month figures show total revenue of about $13 million and basic EPS of around minus $40.87. Over recent periods the company has seen revenue move from roughly $5 million on a trailing basis in Q4 2023 to about $7 million in Q4 2024, then to around $13 million by Q3 2025, even as quarterly basic EPS remained negative...

Colgate-Palmolive (CL) is back on traders radar after RBC Capital bumped the stock to an outperform rating, arguing that consistent organic growth and solid execution could support a gradual sentiment reset. See our latest analysis for Colgate-Palmolive. That upgrade comes after a tough stretch, with the year to date share price return sitting around negative 13 percent and the 1 year total shareholder return near negative 14 percent. However, a positive 3 year total shareholder return just...

If you have ever wondered whether CoreCivic is quietly trading below what it is really worth, you are not alone and this article is going to walk through that question step by step. Despite being down 13.0% year to date and 13.6% over the last year, the stock has climbed 10.7% in the last month and 155.4% over five years, which reflects how quickly the market can move when expectations change. Recently, investors have been focused on CoreCivic's position in the U.S. corrections and detention...

Wondering if Oceaneering International at around $26 a share is still a smart buy, or if the big gains are already behind it? You are in the right place to unpack what the current price really implies. The stock has slipped about 3.3% over the last week but is still up 11.7% over the past month. This follows a flat 0.7% gain over the last year and a much stronger 79.9% and 215.4% over the past 3 and 5 years respectively, a mix that hints at both consolidation and long term momentum. Recent...

Arcus Biosciences and partner Gilead Sciences have discontinued the Phase 3 STAR-221 trial after an interim analysis showed domvanalimab plus zimberelimab and chemotherapy did not improve overall survival versus nivolumab plus chemotherapy in first-line advanced gastric and esophageal cancers, though safety remained comparable. This setback is prompting Arcus to redirect development resources toward its HIF-2α inhibitor casdatifan and emerging small-molecule immunology and inflammation...

Wondering if Coeur Mining is still a bargain after its big run, or if you are late to the party? This breakdown will help you decide whether the current share price makes sense or is getting ahead of itself. The stock has rocketed, with shares up 8.8% over the last week, 10.4% over the past month, and 178.2% year to date, on top of a 163.0% gain over the last year and a 427.5% rise over three years. Recent moves have been closely tied to shifting sentiment around precious metals, as...

Wondering if Mondelez International is quietly turning into a value opportunity while the market looks elsewhere? You are not alone. The stock is down around 1.6% over the last week, 5.2% over the past month, and roughly 9.2% year to date. It is about 10.1% lower than a year ago despite being modestly positive, up 4.7%, over five years. Recently, investors have been digesting a mix of macro headlines around consumer spending, shifting brand loyalty in snacks and confectionery, and ongoing...

Universal Health Services (UHS) just delivered a standout third quarter, with revenue growth outpacing every major hospital peer and topping Wall Street forecasts, while full year EPS guidance also came in ahead of expectations. See our latest analysis for Universal Health Services. The strong quarter arrives after a solid run in the stock, with the share price at about $222.60 and a 90 day share price return of 16.11% pointing to building momentum. The 3 year total shareholder return of...

In recent days, borrowers filed a civil class action lawsuit accusing D.R. Horton and its mortgage arm DHI Mortgage of understating property tax escrows in new-build mortgage quotes, allegedly violating federal escrow and disclosure rules. The case, still at an early stage with D.R. Horton denying all allegations, raises questions about compliance controls in its vertically integrated homebuilding-and-mortgage model. We’ll now examine how these allegations around property tax disclosures and...

If you are looking at Paycom Software and wondering whether the recent share price still reflects its true potential, you are not alone. This stock has quietly become a lightning rod for value focused investors. Despite a modest 0.5% gain over the last week, the stock is still down 0.6% over 30 days and a steep 28.4% over the past year, with longer term returns of 45.4% and 61.4% in the red over three and five years, which naturally raises the question of whether sentiment has overshot the...

Labcorp Holdings (LH) just beat earnings expectations, but the stock is reacting more to management’s cautious tone after cutting revenue growth targets for its contract research unit and trimming its full year outlook. See our latest analysis for Labcorp Holdings. At around $264.18 per share, Labcorp’s recent weakness, reflected in a roughly 5 percent 3 month share price return, contrasts with a solid 5 year total shareholder return of about 57 percent. This suggests momentum has cooled as...

Wondering if AutoZone is still a smart buy after such a long run up, or if the easy money has already been made, you are not alone. The stock is up an impressive 191.5% over 5 years and 44.8% over 3 years, but more recently it has slipped 9.9% over the last week and 9.1% over the past month, leaving year to date gains at 6.0% and 1 year returns at 2.2%. Recent attention has focused on AutoZone's ability to keep winning in the do it yourself and commercial repair markets, as investors weigh...

Kolon Industries has announced in the past that it will invest in a new Vietnam plant to produce airbag materials for Autoliv, creating a fully integrated airbag manufacturing base in Ho Chi Minh City expected to be operational by 2028 under a long-term supply arrangement. This expansion deepens Autoliv’s access to critical airbag components in a cost-competitive region, potentially reinforcing supply resilience and supporting its global leadership in passive vehicle safety. We’ll now...

Wondering if Solaris Energy Infrastructure is still a smart buy after its huge run up, or if you are arriving late to the party? We are going to unpack what the current share price really implies about future returns. Even after a sharp pullback of 16.8% over the last week and a modest 2.6% slide over the past month, the stock is still up 56.4% year to date and 67.0% over the last year, capping a 439.8% three year and 540.9% five year run. Those swings have come as investors digest a series...

Wondering if Hormel Foods at around $24 a share is a bargain or a value trap? You are not alone, and this breakdown is designed to give you a clear, no-jargon view. The stock has bounced about 8.0% over the last month after a long slide, with the price still down roughly 23.9% over the past year and more than 40% over five years, which signals a big gap between past expectations and today’s sentiment. That recent rebound has come as investors refocus on Hormel’s portfolio reshaping and cost...

If you are wondering whether ON Semiconductor is quietly turning into a value opportunity, or if the market still sees too much risk in the story, you are not alone. The stock has inched up about 0.4% over the last week and 11.5% over the past month, but it is still down 10.9% year to date and 16.7% over the last year, a reminder that past enthusiasm has cooled even though the 5 year return sits at 74.3%. Recently, investors have been weighing ON Semiconductor's positioning in electric...

GigaCloud Technology stock moves GigaCloud Technology (GCT) has quietly turned into a strong momentum story, with the stock up about 26% over the past month and roughly 35% in the past 3 months. See our latest analysis for GigaCloud Technology. The latest jump takes GigaCloud Technology’s share price to $40.37, with a powerful year to date share price return of around 112 percent and a three year total shareholder return above 600 percent, suggesting momentum is still building as investors...

The Lovesac Company recently reported third-quarter fiscal 2026 results showing largely flat net sales at US$150.17 million alongside a wider net loss of US$10.55 million and higher loss per share than a year earlier. Despite weak profitability and below-consensus guidance for the key holiday quarter and full fiscal 2026, management is still investing in product innovation, domestic manufacturing, and marketing to expand its household reach over the long term. We’ll now examine how Lovesac’s...